The appointment of a distinguished neurosurgeon and health system leader to the Quality and Compliance Committee signals a strategic focus on clinical excellence and regulatory adherence.
Filing excerpt
Labcorp Holdings Inc. (the “Company”) today announced that on February 6, 2026, the Company’s Board of Directors (the “Board”) appointed John H. Sampson, M.D., Ph.D., as a member of the Board, effective February 9, 2026.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-8kboardChangeGet every 8-K signal for Labcorp and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Labcorp this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/9992538c-3dd9-4fc6-8d34-a558829fcadd returns this record as JSON. POST /v1/companies/enrich returns every signal for labcorp.com.
{
"signal_id": "9992538c-3dd9-4fc6-8d34-a558829fcadd",
"signal_type": "sec-8k",
"signal_subtype": "boardChange",
"detected_at": "2026-02-10T08:53:22.093+00:00",
"company": {
"name": "Labcorp",
"domain": "labcorp.com"
},
"data": {
"detail": "The appointment of a distinguished neurosurgeon and health system leader to the Quality and Compliance Committee signals a strategic focus on clinical excellence and regulatory adherence. This change could trigger reviews of vendors and systems related to quality management, compliance software, and clinical trial support.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Labcorp appoints Dr. John H. Sampson to Board and Quality & Compliance Committee",
"excerpts": "Labcorp Holdings Inc. (the “Company”) today announced that on February 6, 2026, the Company’s Board of Directors (the “Board”) appointed John H. Sampson, M.D., Ph.D., as a member of the Board, effective February 9, 2026.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/920148/000092014826000019/lh-20260206.htm",
"filing_date": "2026-02-09",
"filing_year": 2026,
"fiscal_year_end": "02/06",
"sales_relevance": "Strategic direction shift",
"signal_category": "leadership"
}
}
curl https://signals.autobound.ai/v1/signals/9992538c-3dd9-4fc6-8d34-a558829fcadd \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"labcorp.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.